TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) Total liabilities 2023–2025
TONIX PHARMACEUTICALS HOLDING CORP. (TNXP) total liabilities at each fiscal year-end, per SEC filings.
$32.0MFY2025 · since FY2023: $48.9M → $32.0M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $32.0M | +37.2% |
| FY2024 | $23.3M | -52.3% |
| FY2023 | $48.9M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice
More TNXP financial trends
TNXP RevenueTNXP Net incomeTNXP Net marginTNXP Gross profitTNXP Gross marginTNXP Operating incomeTNXP Operating marginTNXP Operating cash flowTNXP Free cash flowTNXP Capital expendituresTNXP Return on equityTNXP Stock buybacksTNXP Dividends paidTNXP Total assetsTNXP Shareholders’ equityTNXP overview →